-
Cancer Control in the CommunitySuccessful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
-
Healthy Habits
Vitamin D DoubtsIn a clinical trial, vitamin D supplements did not appear to reduce cancer risk.
by Jane C. Hu
-
Forward Look
Tinkering With T CellsNew cancer treatments use patients' own modified immune cells.
by Kate Yandell
-
Challenges Remain for Kids With CancerMore children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
-
Forward Look
Palliative Care Can Help a Wide Range of PatientsPalliative care can help all cancer patients, not just late-stage ones.
by Yasmine Iqbal
-
Healthy Habits
A Virtuous CycleBicycling to work can be a way to build exercise into your day.
by Kate Yandell
-
Forward Look
By the NumbersTalking to doctors about cancer and its treatment often means being bombarded with numbers, from percentages to risk ratios. Yet many people don’t fully comprehend what the numbers mean. As a result, cancer patients may not understand their prognosis, the effect a treatment might have, or their risk for recurrence. Photo © iStock / PeterHermesFurian To […]
by Cameron Walker
-
Forward Look
The Evolution of CancerQ&A with molecular biologist James DeGregori on cancer development.
by Sue Rochman
-
Forward Look
Breast Density MattersBreast cancer risk factor may be overlooked.
by Kendall K. Morgan
-
Forward Look
More Options for Adolescents in Clinical TrialsNew recommendations support inclusion of teens in adult studies.
by Susan Kreimer
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
